PhageLab
PrivateLast Round
Series A
Jan 23, 2024
Total Funding Raised
$44.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PhageLab operates in Healthcare & Life Sciences and is based in Santiago. Its latest recorded funding round was a Series A round in January 2024.
PhageLab is a biotechnology company that develops precision bacteriophage treatments to reduce the overuse of antibiotics and control bacteria in the livestock industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhageLab Comparables
Compare PhageLab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sciphage | 83% | |
| Phagos | 83% | |
| Proteon Pharmaceuticals | 82% |
For institutional investors. Book with your work email.
PhageLab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 23, 2024 | ||||
| Series A | May 23, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PhageLab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nazca | Series A |
| Humboldt Fund | Series A |
| Collaborative Fund | Series A |
| Waterlemon | Series A |
| The Yield Lab | Convertible Debt |
| Kaszek | Series A, Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 42% to 2.2K.
- Jan 23, 2024
Raised $11M with participation from Collaborative Fund and Nazca.
For institutional investors. Book with your work email.
PhageLab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PhageLab's valuation, stock price, and market status.
Is PhageLab a public or private company?
PhageLab is a private company.
What is the current stock price of PhageLab?
PhageLab is a private company, so its shares have no public market price. Caplight tracks PhageLab's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PhageLab worth (valuation)?
Valuation information for PhageLab is not publicly available.
Can I buy PhageLab stock?
PhageLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PhageLab's last funding round?
PhageLab's most recent funding round was Series A on January 23, 2024.
Who are the main investors in PhageLab?
Key investors in PhageLab include Kaszek.
Will PhageLab IPO soon?
No public IPO plans have been announced for PhageLab.
How can I track PhageLab secondary market activity?
Caplight tracks bids, offers, and trades in PhageLab's shares on secondary markets.